What insurance policy changes affect code I25.112?

There are 3 tracked policy changes affecting code I25.112, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I25.112?

Payers that have issued tracked updates for code I25.112 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code I25.112 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I25.112. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I25.112?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

I25.112 Insurance Policy Changes

ICD-10 I25.112 is officially defined as "Atherosclerotic heart disease of native coronary artery with refractory angina pectoris." code I25.112 is referenced in 3 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I25.112 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Aug 18, 2026Medium impact
T-Wave Alternans (CPB 0579, reviewed 2025-09-08)
Aetna considers microvolt T-wave alternans (MTWA) diagnostic testing using the spectral analytic method medically necessary for evaluating persons at risk of sudden cardiac death who meet criteria for implantable cardioverter-defibrillator placement. MTWA testing is experimental, investigational, or unproven for other indications, including diagnosis and risk assessment of acute coronary syndrome, guidance of anti-arrhythmic therapy, and evaluation of the adequacy of medical therapy. CPT 93025 is covered if selection criteria are met, but it is not covered for the diagnosis and risk assessment of acute coronary syndrome or for guiding anti-arrhythmic therapy.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Transmyocardial Revascularization
Transmyocardial laser revascularization may be considered medically necessary for individuals with class III or IV angina who are not candidates for CABG or PTCA and who meet all of the policy criteria. It may also be considered medically necessary as an adjunct to CABG in individuals with documented areas of ischemic myocardium that are not amenable to surgical revascularization, and that adjunct is not separately billable. Percutaneous transmyocardial laser revascularization and all other indications are considered investigational.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Coronary Computed Tomography Angiography with Selective Noninvasive Fractional Flow Reserve
Noninvasive fractional flow reserve following a positive coronary computed tomography angiography may be considered medically necessary to guide decisions about invasive coronary angiography for individuals with stable chest pain and intermediate risk of coronary artery disease (suspected or presumed stable ischemic heart disease). Noninvasive fractional flow reserve that does not meet these criteria is considered investigational. The 10/16/2026 update revised the policy description regarding the Heartflow Analysis and made minor changes to the medically necessary statement.

Watch I25.112

Get one email when a payer policy names I25.112, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

T-Wave Alternans (CPB 0579, reviewed 2025-09-08)

Transmyocardial Revascularization

Coronary Computed Tomography Angiography with Selective Noninvasive Fractional Flow Reserve

What insurance policy changes affect code I25.112?

Which payers have updated policy for code I25.112?

How do I get notified when code I25.112 policy changes?

Why do payers change policies for code I25.112?